Comparative Pharmacology
Head-to-head clinical analysis: DIPHENOXYLATE HYDROCHLORIDE W ATROPINE SULFATE versus MOTOFEN HALF STRENGTH.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIPHENOXYLATE HYDROCHLORIDE W ATROPINE SULFATE versus MOTOFEN HALF STRENGTH.
DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE vs MOTOFEN HALF-STRENGTH
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Diphenoxylate acts as an opioid agonist on mu-opioid receptors in the gastrointestinal tract, reducing peristalsis and increasing intestinal transit time. Atropine sulfate is added at subtherapeutic doses to deter abuse by causing unpleasant anticholinergic effects at high doses.
Motofen Half-Strength contains difenoxin (an opioid agonist) and atropine (an anticholinergic). Difenoxin inhibits gastrointestinal motility by acting on mu-opioid receptors in the gut, reducing peristalsis. Atropine discourages abuse by producing unpleasant anticholinergic effects at supratherapeutic doses.
2.5-5 mg (diphenoxylate) orally 4 times daily until diarrhea controlled; maximum 20 mg/day (diphenoxylate).
Adults: 1 tablet (diphenoxylate 1 mg + atropine 0.0125 mg) orally 4 times daily as needed for diarrhea, up to 8 tablets per day.
None Documented
None Documented
Diphenoxylate: terminal half-life of 2.9-5.8 hours (active metabolite difenoxin: 12-14 hours). Atropine: terminal half-life of 2-4 hours. Clinical context: The long half-life of difenoxin contributes to sustained antidiarrheal effect.
Terminal elimination half-life is 2-3 hours for diphenoxylate, 12-14 hours for atropine. Clinical context: Steady-state achieved within 1 day for diphenoxylate, 3 days for atropine.
Diphenoxylate is excreted primarily in feces (via biliary elimination) as the active metabolite difenoxin and its conjugates; approximately 14% is excreted renally as unchanged drug and metabolites. Atropine is excreted renally (30-50% unchanged) and partially in feces.
Renal (50% as unchanged drug and conjugates), biliary/fecal (30% as metabolites), 20% unknown.
Category C
Category C
Antidiarrheal
Antidiarrheal